Starting
Initialising…
0%
PTEN
Final classification
Likely Benign
PTEN c.-307C>G · p.?
PTEN

The PTEN c.-307C>G (NP_000305.3:p.?) variant has not been observed in somatic cancers in COSMIC and has not been reported in ClinVar.

Gene
PTEN
Transcript
NM_000314.8
HGVS · transcript:coding
NM_000314.8:c.-307C>G
Consequence
N/A
GRCh38
chr10:87864163 C>G
GRCh37
chr10:89623920 C>G
Basis Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework: matched Rule20 (1 Benign.Strong) with applied criteria: BS1 strong; maps to Likely Benign.
Richards et.al., 2015 - Combining rules v3.2.0 criteria-combination framework: matched Rule20 (1 Benign.Strong) with applied criteria: BS1 strong; maps to Likely Benign.
Classification rationale
BS1 Likely Benign
PTEN c.-307C>G

The PTEN c.-307C>G (NP_000305.3:p.?) variant has not been observed in somatic cancers in COSMIC and has not been reported in ClinVar.1 This variant is absent from gnomAD v2.1, but in gnomAD v4.1 it is present at an overall allele frequency of 5.31e-06 and reaches 1.23e-04 in the Ashkenazi Jewish population, which meets the PTEN BS1 strong frequency range and is above the PTEN PM2 subpopulation threshold.2 SpliceAI predicts no significant splice impact for this variant, with a maximum delta score of 0.00, and no PTEN-specific computational evidence supporting a deleterious effect was identified.3

BS1 Likely Benign
Gene diagram · NM_000314.8 · variants mapped to exon structure
PTEN NM_000314.8
Fetching transcript structure from UCSC…
Applied criteria · 1 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports benign
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 5.30724e-06; MAF= 0.00053%, 3/565266 alleles, homozygotes = 0) and has highest observed frequency in the Ashkenazi Jewish population (AF= 0.000122745; MAF= 0.01227%, 2/16294 alleles, homozygotes = 0).
      v2.1
      Absent from gnomAD v2.1.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.00053% · 3 / 565,266
      0 hom
      Ashkenazi Jewish
      2 / 16,294
      0.012%
      European (non-Finnish)
      1 / 316,368
      0.00032%
      + 8 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, African/African American)
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant is absent from ClinVar.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
      Functional No data
      No calibrated functional assay or RNA evidence was identified for this variant.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Somatic evidence
      COSMIC
      This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant cancer hotspot.
      COSMIC ↗
      Sources & reference links
      7Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC